Navigation Links
Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry
Date:5/9/2008

simo, Saint Barnabas joins many of the top hospitals in the United States -- including four of the top five -- as listed on the US News & World Report Honor Roll, which have all adopted Masimo SET as their primary pulse oximetry platform. Clinically proven in more than 100 independent and objective studies, Masimo SET provides the most trustworthy SpO2 readings, even under the most difficult clinical conditions, including patient motion and low peripheral perfusion. These studies demonstrate that Masimo SET delivers improvements in outcomes, safety and efficiency.

Joe E. Kiani, CEO of Masimo, stated, "Saint Barnabas Medical Center's conversion to Masimo SET pulse oximetry ensures they have the best of the present and are set for the future with the upgradable Masimo Rainbow SET technology platform. They represent a growing industry trend toward pulse oximetry technologies that have value and relevance into the future. Masimo Rainbow SET is the first pulse oximetry technology platform to pioneer this capability and the only one that can provide the innovation to drive this proposition for hospitals worldwide. We value Saint Barnabas for their commitment to patient care, quality and this vision."

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50
2. ASTAR Air Cargo, The Church of Jesus Christ of Latter-day Saints and DHL to Help Peruvian Earthquake Victims
3. Saint Barnabas Health Care System Expands Business Relationship with Thomson Healthcare
4. Saint Marys Reno RNs Choose CNA/NNOC in Landslide 64 Percent Vote for 500 RNs
5. Revise guidelines for weight gain during pregnancy, says Saint Louis U. obstetrician
6. Providence Saint Joseph Medical Named LA Countys Third Primary Stroke Center
7. MSU engineering team designs innovative medical device
8. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
10. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
11. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)...all/ -- TOFUTTI BRANDS INC.,(Amex: TOF ) today an...nded,March 29, 2008., Net sales for the thirteen ...illion compared with net sales of $4.85 million fo...he discontinuance of certain low profit,margin pro...ale in the 2007,period., For the thirteen weeks e...
(Date:5/13/2008)...sent entirely new platforms, NATICK, Mass., May 1...oration (NYSE: BSX ) today announced U.S. Food an...(TM) cardiac resynchronization therapy,defibrillat...r,defibrillator (ICD). These devices represent ent...den cardiac death and are the result of a,multi-ye...
(Date:5/13/2008)...isk of developing breast cancer, breast ultrasound... than mammography alone, according to results of a...edical Center researchers. , Overall, 40 partici...cases, a dozen lesions were suspicious only on ult...nd and mammography. , The most recent findings...
(Date:5/13/2008)... a screening ultrasound examination to routine mam...phy alone, according to results of a major new cli...dding an ultrasound exam also increases the rate o.... , Results of the clinical trial, conducted by ...(ACRIN) and analyzed by Brown University statistic...
Breaking Medicine News(10 mins):Health News:TOFUTTI Announces First Quarter Results 2Health News:TOFUTTI Announces First Quarter Results 3Health News:TOFUTTI Announces First Quarter Results 4Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 2Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 3Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 4Health News:UT Southwestern researcher: Supplemental breast ultrasound boosts cancer detection 2Health News:Adding ultrasound screening to mammography brings benefits, risks 2
...a surgeons at The Methodist Hospital shows unprece...rd of patients treated with Lucentis? for wet// ag... findings published today in the New England Journ...isual loss and is one of the leading causes of bli...
...nged into the 'very unhealthy' range as a thick sm...keted the city-state.// 'People should stay indoo...vironment Agency's (NEA's) hotline, with the Pollu...at mid-morning and 115 Saturday The all-time high ...
...illager suffering from a serious kidney ailment di...a premier hospital here//, apparently because he c...jumped out of a window of the nephrology ward of t...te of Medical Sciences, where he was being treated...
...ind children can hear now, thanks to the implant o... world of profound// neuro-sensorial auditory defi...adera International Health Centre in Havana, the P...eported. The device turns sounds and speaking sig...
Other Medicine News:Health News:Results for Wet Age-Related Macular Degeneration Show Significant Vision Improvements 2
(Date:5/12/2008)...ewswire-USNewswire/ -- GlaxoSmithKline (GSK),in c...BIG), a leading,academic breast cancer research ne...reast Cancer Cooperative Group (SOLTI), today anno...ill examine the role of TYKERB(R) in the,treatment...patinib and/or,Trastuzumab Treatment Optimization)...
(Date:5/9/2008).../PRNewswire-USNewswire/ -- An emergency,veterinary... Animals (WSPA),is on stand-by in Thailand awaitin...ess and then relieve the suffering of thousands of...nd their livelihoods., WSPA is receiving daily ... of the United Nations (FAO) while preparing its R...
(Date:5/9/2008)...ed in Patients Following Bunionectomy,, TAMPA,...surgery,patients experience intense pain for sever...most common foot surgeries. The investigational pa...ef for patients who had this,surgery, compared to ...dol,also resulted in patients reporting fewer gast...
(Date:5/9/2008)...nt of early pipeline cancer drug candidates, MELB...Cytopia Limited,(ASX: CYT) today announced that it...d development collaboration with Cancer Therapeuti... early stage drug discovery pipeline,of kinase inh...one of the,fastest growing segments of the cancer ...
Breaking Medicine Technology:TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7Animals That Cyclone Survivors Depend on Need Help Now 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 2Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 3Anavex strengthens Board of Directors 2227 1Anavex strengthens Board of Directors 2227 2Anavex strengthens Board of Directors 2227 3Innocoll Announces Closing of 2430 Million Equity Financing Investment 2224 1Innocoll Announces Closing of 2430 Million Equity Financing Investment 2224 2Innocoll Announces Closing of 2430 Million Equity Financing Investment 2224 3Innocoll Announces Closing of 2430 Million Equity Financing Investment 2224 4Innocoll Announces Closing of 2430 Million Equity Financing Investment 2224 5Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 2222 1Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 2222 2Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer 2222 3New report estimates 12 million cancer deaths worldwide 8350 1New report estimates 12 million cancer deaths worldwide 8350 2
... Pa.--(BUSINESS WIRE)--Jun,13, 2007 - Amgen (NASDA...yeth (NYSE:WYE), today announced the presentation ...file of Enbrel(R),(etanercept) was maintained with... juvenile rheumatoid arthritis (JRA) who,completed...toimmune,disease of childhood that is sometimes di...
...icacy with Either Every,Two Weeksn or Monthly Dosi...- New pivotal data,(RAPID 1 and RAPID 2) presented...EULAR) show that Cimzia (certolizumab pegol), the,...ethotrexate,therapy has a rapid and significant ef...rheumatoid arthritis (RA) compared with,methotrexa...
Other Medicine Technology:Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 2Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 3Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 5Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 6Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 7Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 8Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8
Are you looking for an inexpensive, effective Blood and Infusion Warmer? , ,Animec is an economical fluid warmer that uses standard I.V. tubing instead of special disposable sets.
...easy-to-use solution that's perfectly suited to en... ,Symeon's light weight and mobility mean that t...It can also be easily mounted on a wall. And exces...gh the use of the optional unique MultiMed pod tha...
...anesthesia workstation provides an intelligent app...combined to provide true clinical benefits to the ...logy integrates hemodynamic and respiratory monito.... The open interfaces allow the export of monitore...
...acilities where space is a premium Fabius Tiro com...nologies with an ergonomic and compact design. Add...er Infinity patient monitoring range allows you to... sound investment into the future. The open modula...
Medicine Products: